CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,966,069
- in 2 filings, $18.0M under 10b5-1 plans
Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-11 | Krishnan Suma President, R&D | Sale 10b5-1 | −2,110 | $129.10 | $272K | 1,599,206 |
| 2023-09-11 | Krishnan Suma President, R&D | Sale 10b5-1 | −5,008 | $125.23 | $627K | 1,679,330 |
| 2023-09-11 | Krishnan Suma President, R&D | Sale 10b5-1 | −5,452 | $126.17 | $688K | 1,673,878 |
| 2023-09-11 | Krishnan Suma President, R&D | Sale 10b5-1 | −1,873 | $127.18 | $238K | 1,672,005 |
| 2023-09-11 | Krishnan Suma President, R&D | Sale 10b5-1 | −10,557 | $128.37 | $1.4M | 1,661,448 |
| 2023-09-11 | Krishnan Suma President, R&D | Sale 10b5-1 | −2,110 | $129.10 | $272K | 1,659,338 |
| 2023-09-11 | Krishnan Krish S President and CEO | Sale 10b5-1 | −5,008 | $125.23 | $627K | 1,679,330 |
| 2023-09-11 | Krishnan Krish S President and CEO | Sale 10b5-1 | −5,452 | $126.17 | $688K | 1,673,878 |
| 2023-09-11 | Krishnan Krish S President and CEO | Sale 10b5-1 | −1,873 | $127.18 | $238K | 1,672,005 |
| 2023-09-11 | Krishnan Krish S President and CEO | Sale 10b5-1 | −10,557 | $128.37 | $1.4M | 1,661,448 |
| 2023-09-11 | Krishnan Krish S President and CEO | Sale 10b5-1 | −2,110 | $129.10 | $272K | 1,659,338 |
| 2023-09-11 | Krishnan Krish S President and CEO | Sale 10b5-1 | −5,007 | $125.23 | $627K | 1,619,199 |
| 2023-09-11 | Krishnan Krish S President and CEO | Sale 10b5-1 | −5,452 | $126.17 | $688K | 1,613,747 |
| 2023-09-11 | Krishnan Krish S President and CEO | Sale 10b5-1 | −1,874 | $127.18 | $238K | 1,611,873 |
| 2023-09-11 | Krishnan Krish S President and CEO | Sale 10b5-1 | −10,557 | $128.37 | $1.4M | 1,601,316 |
| 2023-09-11 | Krishnan Krish S President and CEO | Sale 10b5-1 | −2,110 | $129.10 | $272K | 1,599,206 |
| 2023-06-30 | Mazzacco Catherine Director | Grant or award · Stock Option (Right to Buy) | +2,180 | 2,180 | ||
| 2023-06-30 | Sutherland Everett Rand Director | Grant or award · Stock Option (Right to Buy) | +6,800 | 6,800 | ||
| 2023-06-30 | ROSSI DINO A Director | Grant or award · Stock Option (Right to Buy) | +6,800 | 6,800 | ||
| 2023-06-30 | Mason Christopher Director | Grant or award · Stock Option (Right to Buy) | +6,800 | 6,800 |
Page 28 of 42 · 828 trades